Skip to main content
Figure 1 | Molecular Cancer

Figure 1

From: Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells

Figure 1

Cell viability and caspase 3/7 activity in breast cancer cells treated with various bisphosphonates. Cell viability (A-C) and caspase 3/7 activity (D-F) in MCF-7, T47D and MDA-MB-231 breast cancer cells treated with 5–100 μM zoledronic acid (ZA, filled triangles), ibandronate (IBN, open triangles), alendronate (ALN, filled squares) and risedronate (RIS, open squares). All data are expressed as means of six different measure points of three independent experiments as percent of controls ± SEM. Significances were calculated with the Mann–Whitney U test (**p < 0.001, *p < 0.01, #p < 0.05).

Back to article page